Fate Therapeutics (FATE)
1.2450 -0.0350 (-2.73%) 15:13 ET [NASDAQ]
1.2300 x 2,600 1.2400 x 2,400
Realtime by (Cboe BZX)
1.2300 x 2,600 1.2400 x 2,400
Realtime 1.2900 +0.0100 (+0.78%) 08:46 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -186,262 | -160,928 | -281,721 | -212,151 | -173,387 |
| Depreciation Amortization | 9,882 | 14,080 | 16,178 | 14,912 | 7,873 |
| Accounts receivable | -1,113 | 36,654 | -29,804 | -3,160 | -5,515 |
| Other Working Capital | -1,958 | 19,182 | -34,710 | 2,098 | -12,773 |
| Other Operating Activity | 56,577 | -41,251 | 81,849 | 35,431 | 144,573 |
| Operating Cash Flow | $-122,874 | $-132,263 | $-248,208 | $-162,870 | $-39,229 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,948 | 118,818 | 202,317 | -273,319 | -156,144 |
| PPE Investments | -730 | -6,153 | -35,566 | -50,704 | -4,932 |
| Investing Cash Flow | $12,218 | $112,665 | $166,751 | $-324,023 | $-161,076 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94,822 | 85 | 9,207 | 453,129 | 282,348 |
| Other Financing Activity | 5,070 | 0 | 0 | 0 | 490 |
| Financing Cash Flow | $99,892 | $85 | $9,207 | $453,129 | $282,838 |
| Beginning Cash Position | 57,047 | 76,560 | 148,810 | 182,574 | 100,041 |
| End Cash Position | 46,283 | 57,047 | 76,560 | 148,810 | 182,574 |
| Net Cash Flow | $-10,764 | $-19,513 | $-72,250 | $-33,764 | $82,533 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122,874 | -132,263 | -248,208 | -162,870 | -39,229 |
| Capital Expenditure | -730 | -6,153 | -35,566 | -50,704 | -4,932 |
| Free Cash Flow | -123,604 | -138,416 | -283,774 | -213,574 | -44,161 |